Company page

Orexo Ab

Orexo Ab, traded under the ticker ORX, is a public company based in Sweden with a market capitalization of approximately 79.66 million USD. The company focuses on developing innovative pharmaceutical products, particularly in the field of addiction treatment and pain management. Orexo is committed to advancing healthcare solutions that improve patient outcomes.